Hangzhou Richerpharm Technology Co., Limited is engaged in the development, production, and marketing of pharmaceutical products, food ingredients, vitamins, intermediates, and chemicals.
Richerharm is headquartered in Hangzhou, China, with three production bases in Shandong, Zhejiang, and Hebei. We have many years of experience in the production of APIs, vitamins, and chemical products. These facilities are certified for GMP, ISO, FAMI-QS, KOSHER, HALAL, and other standards. We fully control our product development, design, and manufacturing processes thanks to our advanced equipment, methods, and inspection facilities.
With key competencies in pharmaceuticals and food health, Richer Pharma has established an extensive business network worldwide. We have Strategic Marketing Partners in Mumbai and Dubai. We are ready to provide you with our best products and services.
Baoyi Pharmaceutical: A global leader in high-end custom-grade excipient technology, with benzaldehyde impurity control below 1 ppm, and tyloxapol breaking the US monopoly and gaining FDA approval. The company has been registered with the CDE, covering both injectable and biopharmaceutical excipients, and boasts outstanding competitiveness in the fields of injectable excipients and biologics.
Shanhe Pharmaceutical Excipients: A leading domestic cellulose excipient company, with 39 CDE registration numbers, 21 of which are for cellulose. Its leading technology for hydropropyl methylcellulose phthalate offers a 30% price-performance ratio superior to imported products, primarily used in oral solid dosage forms and sustained-release materials.
Erkang Pharmaceutical: A globally diversified excipient company, with starch capsule technology patents covering 80 countries. Vertical integration of raw materials has reduced costs by 20%, and its international market share has increased by 25% annually. Its products include pharmaceutical solvents and starch derivatives.
Heda: Full coverage of the cellulose ether industry chain, with a top-three global market share in plant-based capsules. Its high-temperature-resistant formula is compatible with high-speed capsule filling lines, primarily used in plant-based capsules and pharmaceutical packaging.
Weil Pharmaceutical: A company with dual core businesses in synthetic lubricant base oils and pharmaceutical excipients, it has achieved breakthroughs in ether precision polymerization technology, and its injectable-grade excipients are FDA/EDQM certified. It has advantages in injectable solvents and synthetic lubricants.
Prospect Pharmaceuticals: A subsidiary of Hongri Pharmaceuticals, it leads the formulation of national standards for pharmaceutical sucrose. Its low-residue heavy metal technology meets the requirements for genotoxic impurity control. Its products include pharmaceutical sucrose, freeze-dried protective agents, etc.